Terns Pharmaceuticals
TERN
TERN
65 hedge funds and large institutions have $505M invested in Terns Pharmaceuticals in 2022 Q4 according to their latest regulatory filings, with 25 funds opening new positions, 23 increasing their positions, 14 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
44% more funds holding
Funds holding: 45 → 65 (+20)
23.14% more ownership
Funds ownership: 80.54% → 103.68% (+23%)
Holders
65
Holding in Top 10
5
Calls
–
Puts
–
Top Buyers
| 1 | +$74.1M | |
| 2 | +$35.1M | |
| 3 | +$10.9M | |
| 4 |
RI
RTW Investments
New York
|
+$10.2M |
| 5 |
DM
Deerfield Management
New York
|
+$10.1M |
Top Sellers
| 1 | -$1.7M | |
| 2 | -$1.45M | |
| 3 | -$1.26M | |
| 4 |
CC
Commodore Capital
New York
|
-$1.21M |
| 5 |
SB
Samsara BioCapital
Palo Alto,
California
|
-$883K |